OTTAWA – Health Canada is informing Canadians that Marcan Pharmaceuticals has recalled all lots of all MAR-Diltiazem CD products in response to data integrity concerns that could lead to incorrect dosing.
OTTAWA – Health Canada continues to monitor safety information involving Fibristal (ulipristal acetate) as it does for all health products on the Canadian market. The Department is again reviewing the risk of serious liver injury associated with Fibristal, in response to a new international case of liver injury that led to a liver transplantation, and the European Medicines Agency’s recommendation to revoke the marketing authorization of the ulipristal acetate medication called Esmya in Europe.
Health Canada is advising Canadians about unauthorized health products that may pose serious health risks. Thetable belowis updated when Health Canada finds unauthorized health products that are promoted for sexual enhancement, weight loss, as a workout aid, as “poppers,” or for lightening skin or treating skin conditions (such as eczema or psoriasis). These products are labelled to contain or have been tested and found to contain dangerous ingredients. Links to previous tables with affected products are also available below.